The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
Completed
- Conditions
- Asthma
- Registration Number
- NCT01370577
- Lead Sponsor
- AstraZeneca
- Brief Summary
The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 297
Inclusion Criteria
- Patients aged 60 years or more, articulate in Korean
- Patients diagnosed with asthma, at least 1 year in duration.
Exclusion Criteria
- Patients being followed-up for asthma treatment less than 1 year before baseline
- Patients taking immune therapy
- Patients previously enrolled/randomized in the present clinical trial
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Baseline characteristics related to asthma control in the elderly 6 months Asthma exacerbation rate of the elderly during guideline-based stepwise treatments 6 months
- Secondary Outcome Measures
Name Time Method 1. Proportion of controlled, partially controlled, and controlled patients among the elderly patients with asthma in Korea 6 months 2. Baseline characteristics related to asthma specific QOL in the elderly patients with asthma 6 months Mean frequency of PFT, sputum assessments, refill adherence(%), prescription persistence in elderly asthma for the last 1 year before study enrollment 6 months
Trial Locations
- Locations (1)
Research Site
🇰🇷Changwon, Gyeonsangnam-do, Korea, Republic of